BCS1L anticorps

N° du produit ABIN5913372

Détail du produit anti-BCS1L anticorps

Antigène: BCS1L (BCS1-Like (BCS1L))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCS1L est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Purification: Immunogen affinity purified

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol,  pH 7.3

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 24 months. Avoid repeated freeze/thaw cycles.

Détails sur BCS1L

Antigène: BCS1L (BCS1-Like (BCS1L))

Autre désignation: BCS1L (BCS1L Produits)

Synonymes: anticorps BCS, anticorps BCS1, anticorps BJS, anticorps FLNMS, anticorps GRACILE, anticorps Hs.6719, anticorps MC3DN1, anticorps PTD, anticorps h-BCS, anticorps DDBDRAFT_0188274, anticorps DDBDRAFT_0266725, anticorps DDB_0188274, anticorps DDB_0266725, anticorps DDBDRAFT_0184131, anticorps DDBDRAFT_0266726, anticorps DDB_0184131, anticorps DDB_0266726, anticorps 9130022O19Rik, anticorps zgc:56205, anticorps BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone, anticorps mitochondrial chaperone BCS1, anticorps mitochondrial chaperone bcs1, anticorps mitochondrial ATPase, anticorps BCS1-like (yeast), anticorps BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone L homeolog, anticorps BC1 (ubiquinol-cytochrome c reductase) synthesis-like, anticorps BCS1L, anticorps AFUA_3G13000, anticorps CC1G_00820, anticorps CC1G_01181, anticorps CC1G_01608, anticorps CC1G_11035, anticorps CC1G_11036, anticorps Bm1_30135, anticorps bcs1lA, anticorps bcs1lB, anticorps Bcs1l, anticorps bcs1l.L, anticorps bcs1l

Pathways: SARS-CoV-2 Protein Interactome